Extraovular prostaglandin F for early midtrimester abortion

Arthur G. Shapiro

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Twenty patients who were 13 to 15 weeks pregnant received extraovular prostaglandin F2-alpha (PGF) in dosages of 3 mg. every 1 to 3 hours. Ninety-five per cent of the patients successfully aborted and 30 per cent of the patients had retained placental tissue. The mean abortion time was 17 3 4 hours and the average total dose used was 29.2 mg. The abortion time appeared to decrease with parity and had no relationship to weeks of gestation. Only one patient failed to abort after 31 hours of therapy. She required a curettage and was the only patient to develop a postabortion infection. The technique appears to compare favorably with the results of intra-amniotic PGF. Extraovular prostaglandin may therefore be of particular value in inducing abortion in patients who are in the early midtrimester of pregnancy, i.e., when intra-amniotic instillation is technically infeasible.

Original languageEnglish
Pages (from-to)333-336
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume121
Issue number3
StatePublished - Feb 1 1975
Externally publishedYes

Fingerprint

Dinoprost
Second Pregnancy Trimester
Pregnancy
Aftercare
Curettage
Parity
Prostaglandins
Infection

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Extraovular prostaglandin F for early midtrimester abortion. / Shapiro, Arthur G.

In: American Journal of Obstetrics and Gynecology, Vol. 121, No. 3, 01.02.1975, p. 333-336.

Research output: Contribution to journalArticle

@article{286a681745954e9bab0516bcab4119f7,
title = "Extraovular prostaglandin F2α for early midtrimester abortion",
abstract = "Twenty patients who were 13 to 15 weeks pregnant received extraovular prostaglandin F2-alpha (PGF2α) in dosages of 3 mg. every 1 to 3 hours. Ninety-five per cent of the patients successfully aborted and 30 per cent of the patients had retained placental tissue. The mean abortion time was 17 3 4 hours and the average total dose used was 29.2 mg. The abortion time appeared to decrease with parity and had no relationship to weeks of gestation. Only one patient failed to abort after 31 hours of therapy. She required a curettage and was the only patient to develop a postabortion infection. The technique appears to compare favorably with the results of intra-amniotic PGF2α. Extraovular prostaglandin may therefore be of particular value in inducing abortion in patients who are in the early midtrimester of pregnancy, i.e., when intra-amniotic instillation is technically infeasible.",
author = "Shapiro, {Arthur G.}",
year = "1975",
month = "2",
day = "1",
language = "English",
volume = "121",
pages = "333--336",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Extraovular prostaglandin F2α for early midtrimester abortion

AU - Shapiro, Arthur G.

PY - 1975/2/1

Y1 - 1975/2/1

N2 - Twenty patients who were 13 to 15 weeks pregnant received extraovular prostaglandin F2-alpha (PGF2α) in dosages of 3 mg. every 1 to 3 hours. Ninety-five per cent of the patients successfully aborted and 30 per cent of the patients had retained placental tissue. The mean abortion time was 17 3 4 hours and the average total dose used was 29.2 mg. The abortion time appeared to decrease with parity and had no relationship to weeks of gestation. Only one patient failed to abort after 31 hours of therapy. She required a curettage and was the only patient to develop a postabortion infection. The technique appears to compare favorably with the results of intra-amniotic PGF2α. Extraovular prostaglandin may therefore be of particular value in inducing abortion in patients who are in the early midtrimester of pregnancy, i.e., when intra-amniotic instillation is technically infeasible.

AB - Twenty patients who were 13 to 15 weeks pregnant received extraovular prostaglandin F2-alpha (PGF2α) in dosages of 3 mg. every 1 to 3 hours. Ninety-five per cent of the patients successfully aborted and 30 per cent of the patients had retained placental tissue. The mean abortion time was 17 3 4 hours and the average total dose used was 29.2 mg. The abortion time appeared to decrease with parity and had no relationship to weeks of gestation. Only one patient failed to abort after 31 hours of therapy. She required a curettage and was the only patient to develop a postabortion infection. The technique appears to compare favorably with the results of intra-amniotic PGF2α. Extraovular prostaglandin may therefore be of particular value in inducing abortion in patients who are in the early midtrimester of pregnancy, i.e., when intra-amniotic instillation is technically infeasible.

UR - http://www.scopus.com/inward/record.url?scp=0016409514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016409514&partnerID=8YFLogxK

M3 - Article

C2 - 1115147

AN - SCOPUS:0016409514

VL - 121

SP - 333

EP - 336

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -